CancerFax
person
verifiedCancerFax Verified
schoolMD, PhD

Dr.ย Ji-Yongย Liu

MD, PhD

Director, Genitourinary Oncology

corporate_fareZhongshan Hospital, Fudan University, Shanghai

check_circleBladder Cancer
check_circleProstate Cancer
check_circleKidney Cancer
check_circleImmunotherapy & Targeted Therapy
INSTITUTION
corporate_fareZhongshan Hospital, Fudan University
DEPARTMENT
scienceGenitourinary Oncology
SPECIALTY
medical_servicesBladder, Prostate & Kidney Cancer
LOCATION
location_onShanghai, China
INTERNATIONAL PATIENTS
publicInternational Patients Welcome
person

Ji-Yong Liu

MD, PhD

Prof. Ji-Yong Liu is the Director of Genitourinary Oncology at Zhongshan Hospital, Fudan University, one of China's foremost academic medical centres located in Shanghai. With over 20 years of clinical and research experience, he is a recognised specialist in the surgical and systemic management of urological cancers, including bladder, prostate, and kidney cancers.

Prof. Liu completed his medical training at Fudan University and undertook an international research fellowship in the United States, bringing a global perspective to his clinical practice in Shanghai. His work spans complex surgical procedures such as radical cystectomy as well as systemic therapies including immunotherapy and targeted treatment for genitourinary malignancies. He manages both localised disease and advanced or recurrent cases through a multidisciplinary approach involving surgery, pathology, medical oncology, and imaging review. Zhongshan Hospital, Fudan University has long been a national referral destination for patients with complex cancers and offers remote consultation and international patient support services.

workspace_premium20+Years Experience
calendar_month
M
Visiting Days
public
International Patient Access

CancerFax can coordinate medical record review and consultation support for international patients seeking an expert genitourinary oncology opinion from Prof. Ji-Yong Liu at Zhongshan Hospital, Fudan University.

stars

Why Consider Prof. Ji-Yong Liu?

Prof. Liu brings over two decades of focused genitourinary oncology experience from one of Shanghai's most respected academic hospitals, with an international research background and a multidisciplinary approach to complex urological cancers.

local_hospital
Director at a Leading Academic Centre
Prof. Liu leads the Genitourinary Oncology department at Zhongshan Hospital, Fudan University โ€“ a national referral hospital with a dedicated multidisciplinary oncology programme and international patient services.
science
Expertise in Immunotherapy & Targeted Therapy
In addition to surgery, Prof. Liu applies contemporary systemic approaches including checkpoint inhibitor immunotherapy and molecularly targeted agents for bladder, prostate, and kidney cancers.
school
International Research Training
Prof. Liu completed a research fellowship in the United States alongside his core training at Fudan University, giving him exposure to global oncology standards and clinical research methodologies.
language
English-Consulting Specialist
Prof. Liu consults in both Mandarin and English, making him well positioned to review cases from international patients and communicate directly with referring physicians abroad.
verified_user

Areas of Specialisation

Focused expertise in urological cancers with a multidisciplinary treatment approach

Prof. Ji-Yong Liu's clinical focus centres on the three major genitourinary cancers: bladder cancer, prostate cancer, and kidney cancer. He manages patients across the full disease spectrum from early-stage localised tumours to advanced or metastatic disease requiring combined surgical and systemic strategies.

Genitourinary Oncology Specialties

Bladder Cancer

Comprehensive surgical and systemic management of bladder tumours, including both non-muscle-invasive and muscle-invasive disease.

starsSurgical Management
  • arrow_rightTransurethral resection of bladder tumour (TURBT) for diagnosis and staging
  • arrow_rightRadical cystectomy for muscle-invasive or high-risk bladder cancer
  • arrow_rightUrinary diversion and reconstruction planning
starsSystemic Therapy for Bladder Cancer
  • arrow_rightCheckpoint inhibitor immunotherapy for advanced urothelial carcinoma
  • arrow_rightTargeted therapy based on tumour molecular profiling
  • arrow_rightNeoadjuvant and adjuvant chemotherapy coordination

Prostate Cancer

Management of prostate cancer from active surveillance through to advanced disease, with attention to both functional and oncological outcomes.

starsLocalised Prostate Cancer
  • arrow_rightStaging evaluation using biopsy, PSA, MRI, and bone scan findings
  • arrow_rightSurgical and non-surgical treatment planning for localised disease
  • arrow_rightActive surveillance for suitable low-risk cases
starsAdvanced Prostate Cancer
  • arrow_rightHormonal therapy and androgen deprivation strategies
  • arrow_rightTargeted therapy for castration-resistant prostate cancer (CRPC)
  • arrow_rightMultidisciplinary review for metastatic disease

Kidney Cancer

Evaluation and treatment of renal cell carcinoma and other kidney tumours, including advanced disease requiring systemic therapy.

starsSurgical Approaches
  • arrow_rightRadical and partial nephrectomy planning for renal tumours
  • arrow_rightAssessment of surgical candidacy based on tumour size, location, and stage
starsSystemic Therapy for Kidney Cancer
  • arrow_rightTargeted therapy with tyrosine kinase inhibitors (TKIs) for advanced RCC
  • arrow_rightImmunotherapy combinations for selected metastatic kidney cancer cases
  • arrow_rightSequential systemic treatment planning for recurrent or progressive disease
Clinical Focus Areas
check_circleBladder Cancer โ€“ Surgical & Systemic
check_circleProstate Cancer โ€“ Localised & Advanced
check_circleKidney Cancer โ€“ Renal Cell Carcinoma
check_circleImmunotherapy for GU Cancers
check_circleTargeted Therapy
check_circleMultidisciplinary Oncology Review
medical_services

Procedures Performed

Surgical procedures and clinical treatment approaches in genitourinary oncology

Prof. Liu's clinical services span surgical oncology and systemic cancer treatment for genitourinary malignancies. His practice includes major urological surgery, second opinions for complex cases, systemic treatment planning, and ongoing disease monitoring.

Bladder Cancer Surgery

Complex Disease

Surgical management of bladder cancer including cystectomy and urinary reconstruction.

Surgical Options
arrow_rightTransurethral resection of bladder tumour (TURBT)
arrow_rightRadical cystectomy with urinary diversion
arrow_rightAssessment of lymph node involvement and surgical margins

Systemic & Medical Oncology

Medical Oncology

Chemotherapy, immunotherapy, and targeted therapy for bladder, prostate, and kidney cancers.

Treatment Approaches
arrow_rightCheckpoint inhibitor immunotherapy for urothelial and renal cancers
arrow_rightTargeted therapy based on biomarker and molecular profiling
arrow_rightChemotherapy protocols for muscle-invasive bladder cancer
arrow_rightAndrogen deprivation therapy and CRPC management

Targeted Therapy Planning

Targeted Therapy

Molecularly guided treatment planning for genitourinary cancers using biomarker data.

Targeted Treatment
arrow_rightTKI selection for advanced renal cell carcinoma
arrow_rightPARP inhibitors and novel agents for eligible prostate cancer patients
arrow_rightFGFR-targeted therapy for selected bladder cancer cases

Second Opinion & Complex Case Review

Second Opinion

Expert case review for patients seeking a second opinion on diagnosis or treatment strategy for genitourinary cancers.

Case Review Services
arrow_rightPathology and imaging review for diagnosis confirmation
arrow_rightTreatment strategy assessment for complex or recurrent cases
arrow_rightInternational consultation coordination through CancerFax
menu_book

Research & Publications

Genitourinary oncology research and clinical contributions

Prof. Ji-Yong Liu has contributed to genitourinary oncology research through his work at Zhongshan Hospital, Fudan University, and his earlier research fellowship training in the United States. His research interests include bladder cancer diagnosis and treatment, surgical outcomes in urological oncology, and systemic therapy approaches for advanced genitourinary cancers.

Genitourinary Oncology Research
arrow_rightBladder cancer diagnosis, staging, and surgical outcomes
arrow_rightImmunotherapy and targeted therapy for advanced urothelial carcinoma
arrow_rightProstate cancer management including castration-resistant disease
arrow_rightKidney cancer systemic treatment strategies
arrow_rightMultidisciplinary genitourinary oncology at Zhongshan Hospital, Fudan University
Research Profile

A detailed publication list for Prof. Ji-Yong Liu is being compiled. Please contact CancerFax for further information on his research profile and clinical interests.

school

Education & Training

Prof. Ji-Yong Liu completed his core medical and postgraduate training at Fudan University in Shanghai and undertook an international research fellowship in the United States, establishing a strong foundation in both clinical urology and translational oncology research.

scheduleExact graduation years and fellowship institution are pending verification with the hospital profile.
work_history

Clinical Experience

Prof. Ji-Yong Liu has built over 20 years of clinical experience in genitourinary oncology at Zhongshan Hospital, Fudan University, progressing to his current role as Director of the Genitourinary Oncology department.

Director, Genitourinary Oncology
Zhongshan Hospital, Fudan University
Department of Genitourinary Oncology
check_circleSurgical and systemic management of bladder cancer
check_circleAdvanced prostate cancer treatment including CRPC
check_circleKidney cancer surgery and targeted systemic therapy
check_circleMultidisciplinary genitourinary oncology case review
check_circleInternational patient consultation and case coordination
check_circleClinical research in urological malignancies
language

Languages & International

Prof. Ji-Yong Liu consults in the following languages.

๐Ÿ‡ฌ๐Ÿ‡งEnglish
๐Ÿ‡จ๐Ÿ‡ณMandarin Chinese
Interpreter Support Available

CancerFax can coordinate professional medical interpreter support for international patients whose preferred language is not covered by Prof. Liu's consultation languages.

CancerFax can coordinate professional medical interpreter support for patients consulting in other languages.

support_agentHow CancerFax Helps

How CancerFax Helps You Access Dr. Ji-Yong Liu

CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Ji-Yong Liu's team โ€” with full coordination from initial inquiry to consultation.

description

Medical Report Review

Free review of your pathology results, imaging, molecular profiling, and treatment history โ€” prepared as a structured clinical summary for Dr. Ji-Yong Liu's team.

medical_services

Treatment Eligibility Screening

CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Ji-Yong Liu before you travel, so you arrive with a clear pathway.

send

Case Submission

We coordinate direct case submission to Dr. Ji-Yong Liu's department, including all documentation required for clinical review and appointment scheduling.

calendar_month

Appointment & Consultation Coordination

CancerFax manages appointment scheduling with Dr. Ji-Yong Liu's team, confirming availability and aligning timelines with your travel plans.

flight_takeoff

Travel, Visa & Logistics Support

We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.

support_agent

Follow-Up & Continuity of Care

After your consultation or treatment, CancerFax facilitates communication between Dr. Ji-Yong Liu's team and your home oncologist for seamless post-treatment follow-up.

quiz

Frequently Asked Questions About Prof. Ji-Yong Liu

Prof. Ji-Yong Liu specialises in genitourinary oncology, with a clinical focus on bladder cancer, prostate cancer, and kidney cancer (renal cell carcinoma). He manages both localised and advanced disease, including complex and recurrent cases requiring surgical and systemic treatment strategies.

International patients can request a case review by submitting their medical records, pathology reports, imaging studies, and treatment history through CancerFax. The CancerFax team will review the documentation, prepare the case, and coordinate the next steps with Zhongshan Hospital, subject to clinical acceptance and availability. Prof. Liu consults in both English and Mandarin.

A second-opinion request can be submitted through CancerFax with the patient's pathology report, imaging files (CT, MRI, PET-CT where available), recent blood results, and a summary of previous treatments. Prof. Liu can review genitourinary oncology cases from patients who have received an initial diagnosis and are seeking an expert opinion before proceeding with surgery or systemic therapy.

Zhongshan Hospital is a major teaching hospital affiliated with Fudan University in Shanghai, China. It was founded in 1937 and is a national referral centre for complex medical and oncological cases. The hospital offers multidisciplinary team consultations, remote consultation services, and support for international patients. The Department of Genitourinary Oncology is led by Prof. Ji-Yong Liu.

For a genitourinary cancer consultation with Prof. Ji-Yong Liu, patients should prepare the following: a recent diagnostic pathology report (biopsy or surgical specimen), CT or MRI scan reports and DICOM image files where available, PSA results or other relevant tumour marker reports (depending on the cancer type), details of previous surgeries or systemic treatments, and a summary of current symptoms and medications. CancerFax can assist with organising and translating documents for submission.

Yes. Prof. Liu manages advanced and metastatic genitourinary cancers, including muscle-invasive bladder cancer, castration-resistant prostate cancer (CRPC), and metastatic renal cell carcinoma. His treatment approach for advanced disease includes immunotherapy, targeted therapy, and multidisciplinary care coordination. International patients with advanced disease are encouraged to submit their records through CancerFax for an initial review.

sendGet Expert Oncology Guidance

Connect with Ji-Yong Liu Today

Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.

Free case review ยท No commitment ยท Response within 24 hours ยท Available in 12+ languages

Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.

upload_fileUpload ReportschatWhatsApp